Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study - Concepedia

Concepedia

Publication | Open Access

Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study

DOI Full Paper Access

23

Citations

16

References

2023

Year

Guy de Bruyn, Joyce Wang, Annie Purvis, Martin Sanchez Ruiz, Haritha Adhikarla, Saad Alvi, Matthew Bonaparte, Daniel C. Brune, Agustin Bueso, Richard Canter,

EClinicalMedicine

References

	Year	Citations

Page 1